Colorectal cancer screening in average risk individuals
- 1 March 2005
- journal article
- review article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 16 (2) , 171-188
- https://doi.org/10.1007/s10552-004-4027-z
Abstract
Colorectal cancer is the third leading type of cancer, and the second leading cause of cancer-related death in the United States. Prevention of colorectal cancer should be achievable by screening programs that detect adenomas in asymptomatic patients and lead to their removal. In this manuscript, we review the major screening modalities, the advantages and disadvantages of each approach, the data supporting their use, and various issues affecting the implementation of each test. Screening guidelines will be reviewed, and future techniques for colorectal cancer screening examined.Keywords
This publication has 119 references indexed in Scilit:
- The evolution to stool DNA testing for colorectal cancerAlimentary Pharmacology & Therapeutics, 2004
- Virtual Colonoscopy — Promising, but Not Ready for Widespread UseNew England Journal of Medicine, 1999
- A Comparison of Virtual and Conventional Colonoscopy for the Detection of Colorectal PolypsNew England Journal of Medicine, 1999
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Neoplasia distal to the splenic flexure in patients with proximal colon cancerGastrointestinal Endoscopy, 1996
- Sigmoidoscopy Use Among Primary Care PhysiciansPreventive Medicine, 1995
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Problems in the colonoscopic localization of tumors: Continued value of the barium enemaGastrointestinal Radiology, 1987
- Analysis of relative survival and proportional mortalityComputers and Biomedical Research, 1974